The Low Sodium White Corundum segmentation by application delineates three principal demand drivers: pharmaceutical formulations, food‑and‑beverage fortification, and industrial processing aids. In the pharmaceutical arena, the mineral’s high purity and low sodium profile support controlled‑release drug matrices, contributing roughly 45 % of total market revenue due to stringent regulatory adoption and premium pricing. The food‑and‑beverage sector accounts for about 35 % of sales, where manufacturers exploit the compound’s mineral stability to enhance nutritional labeling while meeting sodium‑reduction targets mandated by health authorities. Industrial uses—primarily as a catalyst support in fine‑chemical synthesis and as a refractory additive—represent the remaining 20 % of the market, reflecting lower unit values but broader volume consumption. Collectively, these application categories shape the market’s growth trajectory, with each segment’s proportion directly influencing production scaling, pricing structures, and R&D investment priorities.